BioAge Labs, Inc.
Industry
- Pharmaceuticals
- Digital Health
- Artificial Intelligence
- Biotechnology
- Drug Discovery Technologies
Latest on BioAge Labs, Inc.
When Ann Beliën watched her father struggle with age-related diseases that didn’t respond to conventional treatments, she faced a choice that would define her career. She could accept the pharmaceutic
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Taiho Sends Benz LSD1 Inhibitor Fo
Biopharma merger and acquisition value for the fourth quarter of 2024 reached $9.4bn from 34 transactions, 15 of which had disclosed values. At the top was H. Lundbeck’s $2.6bn purchase of publicly tr
Another company joined the burgeoning obesity therapy space on 28 January, as Versant Ventures-backed Helicore Biopharma unveiled a $65m series A financing and initial plans to take a first-in-class